5-Panel + EXP OPI Oral Drug Test
This advanced oral drug screening detects five core substances—THC, cocaine, methamphetamine, PCP, and opiates—plus expanded opioid classes including oxycodone, oxymorphone, hydrocodone, and hydromorphone. The 5-Panel + EXP OPI Oral Drug Test is ideal for employers who need a fast, non-invasive test that also covers today’s most commonly abused prescription painkillers.
Using a simple mouth swab, this test offers easy, observed collection—making it hard to tamper with and convenient to administer. All results are reviewed and certified by a Medical Review Officer (MRO), giving you clarity, consistency, and full compliance support.
How It Works
- Saliva collected via oral swab under direct supervision.
- Lab screens for THC, cocaine, meth, PCP, and expanded opioids.
- All positive results confirmed via MRO review using B-sample protocol.
When to Use It
- For safety-sensitive roles where opioid use poses risk.
- To screen healthcare or caregiving roles exposed to prescription meds.
- When you want expanded detection without urine testing.
TAT & Fees
- Turnaround time: 1–2 business days.
- Includes MRO review and all lab confirmation costs.
- Volume pricing available upon request.
Why It Matters
Prescription opioid misuse continues to impact workplace safety across industries. This enhanced oral panel ensures you’re covering both traditional illicit substances and high-risk prescription painkillers. By offering observed, tamper-resistant collection with a modern lab workflow, this test gives employers confidence in hiring decisions and post-incident investigations—without needing invasive sample methods.
Use-Cases
- Home healthcare agencies screening mobile caregivers.
- Construction or logistics firms adding opioid screening post-accident.
- Staffing agencies placing workers in high-compliance environments.
5-Panel + EXP OPI Oral Drug Test FAQs
Q: What drugs are included in this expanded panel?
A: THC, cocaine, methamphetamine, PCP, plus oxycodone, oxymorphone, hydrocodone, and hydromorphone.
Q: Is the test observed?
A: Yes, all oral collections are directly observed by lab staff.
Q: Are results legally defensible?
A: Yes, results are confirmed by a certified MRO and follow standard B-sample protocols.
Q: Can this be used in a DOT setting?
A: No, this is a non-DOT test. For DOT roles, see our 10-panel DOT option.
Q: How are candidates notified to test?
A: We send electronic instructions directly to their smartphone via SMS and email.
Authoritative Source
Learn more about drug testing compliance from SAMHSA, the EEOC, and the FDA. Edify is a proud member of the Professional Background Screening Association (PBSA).
Stay Updated with EDIFY Insights Newsletter
Get compliance tips, background screening updates, and HR best practices delivered straight to your inbox.
